TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: A clinically study [71] indicated that poor TKI responders had an enrichment of genes associated with the TGF-β and TNF-α pathways and a quiescence signature that maintains leukemia-initiating cells in chronic myeloid leukemia [72,73].